Press Releases
San Juan Capistrano, CA – October 30, 2020
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
New case report offers first known direct visualization of percutaneous Ellipsys fistula
Dublin, Ireland – September 30, 2020
Avenu’s Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic’s Commitment to Improving Outcomes for Patients with End-Stage Renal Disease
North Chesterfield, VA – September 3, 2020
New study has important patient safety implications, as shortening dialysis timeline reduces reliance on riskier vascular access procedures
San Juan Capistrano, CA – July 21, 2020
Large study in Journal of Vascular Surgery offers roadmap for more widespread use of percutaneous fistula creation
San Juan Capistrano, CA – March 3, 2020
Ellipsys System Offers Significant Advantages for Creating Dialysis Access, Physicians Say
Dr. Jeffrey Hull Awarded First Place for Presentation at 16th Annual ASDIN Meeting
San Juan Capistrano, CA – December 18, 2019
Two-year Ellipsys data featured at annual Controversies in Dialysis Access (CiDA) Meeting
Innovative endoAVF technology is a ‘true paradigm shift’ in dialysis access, leading physicians say
Blanchardville, WI – December 5, 2019
Kidney Patients Report Positive Experiences with Novel Approach to Dialysis Access
Landmark study reports greater success with minimally invasive vascular access procedure
Tempe, AZ – December 6, 2018
Local Interventional Nephrologists Randy Cooper, MD and Umar Waheed, MD, Pioneer Breakthrough Endovascular Arteriovenous Fistula (endoAVF®) Technology for ESRD Patients
Washington, DC – November 15, 2018
Avenu’s Endovascular Arteriovenous Fistula (endoAVF®) Technology for ESRD Patients Receives Favorable Medicare Reimbursement Code while Exhibiting at Controversies in Dialysis Access Meeting
San Juan Capistrano, CA – June 26, 2018
Breakthrough Endovascular Arteriovenous Fistula (endoAVF®) Technology Approved for Hemodialysis Access
San Juan Capistrano, CA – June 1, 2016
Avenu Medical Receives CE Mark Approval for the Ellipsys® Vascular Access System
Company also completes full patient enrollment for pivotal Phase III clinical trial in the United States